NGS is also to detect gene mutation in TP53, ATM, NOTCH1, SF3B1, MYD88, and BIRC3; all the aforementioned genes are related to increased susceptibility of patients to develop CLL [58,136,137]. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.